L. V. Wilton - Concepedia

Concepedia

Author

L. V. Wilton

Drug Safety Research Unit

Also Known As

L V Wilton, L. V. WILTON, L. V. Wilton, L.V. Wilton, Lauren Wilton, Lynda V Wilton

28

Publications

1.1K

Citations

16

H-Index

62

Concepts

All Affiliations

Drug Safety Research Unit University of Portsmouth

LV

About

L. V. Wilton is an author at Drug Safety Research Unit specializing in medicine, pharmacoepidemiology, and patient safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	386
2	Public Health	3	3	131
3	Business	1	1	44
4	Language Studies	1	1	44
5	Social Sciences	1	1	44

L. V. Wilton

×

18

Publications

1.1K

Citations

15

H-Index

	Year	Citations
Underreporting of suspected adverse drug reactions to newly marketed (“black triangle”) drugs in general practice: observational study Richard M. Martin, L. V. Wilton, Ronald D. Mann BMJ	1998	153
The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in England L. V. Wilton, G. L. Pearce, Richard M. Martin, BJOG An International Journal of Obstetrics & Gynaecology	1998	148
Safety of Long‐Term Lamotrigine in Epilepsy F. J. Mackay, L. V. Wilton, G. L. Peace, Epilepsia	1997	147
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoring. W.H.W. Inman, Nigel S. B. Rawson, L. V. Wilton, BMJ HypertensionHeart FailureEnzyme InhibitorPharmacotherapyPrescription-event Monitoring	1988	113
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies L. V. Wilton, G. L. Pearce, Ronald D. Mann British Journal of Clinical Pharmacology	1996	112
Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failure. C. Speirs, C. T. Dollery, W.H.W. Inman, BMJ HypertensionHeart FailurePharmacotherapyNephrologyRenal Function	1988	54
The safety of valsartan: results of a postmarketing surveillance study on 12 881 patients in England Pipasha Biswas, L. V. Wilton, S W Shakir Journal of Human Hypertension Drug SafetyPreventive MedicineHealth PolicyPatient SafetyClinical Epidemiology	2002	48
The safety of risperidone: a post-marketing study on 7684 patients F. J. Mackay, L. V. Wilton, G. L. Pearce, Human Psychopharmacology Clinical and Experimental Geriatric PsychiatryPsychotropic MedicationPsychopharmacologyPharmacotherapyPrescription-event Monitoring	1998	44
Visual field defect associated with vigabatrin: observational cohort study L. V. Wilton, Myles D. B. Stephens, Ronald D. Mann BMJ Ocular DiseaseEast Asian StudiesEconomic DevelopmentIncome DistributionIncome Inequality	1999	44
Evaluation of the safety of sildenafil for male erectile dysfunction: experience gained in general practice use in England in 1999 A. Boshier, L. V. Wilton, Saad Shakir British Journal of Urology	2004	44

Page 1